Pharma Partnerships: When Drug Companies and Nicotine Companies Join Forces
Nicotine companies are partnering with pharmaceutical firms to develop and market reduced-risk products. The partnerships combine pharma's regulatory expertise with nicotine's consumer reach. The convergence raises questions about credibility and conflict of interest.
A nicotine pouch developed by a pharmaceutical company and distributed by a consumer nicotine brand—this is the emerging model. Pharma brings regulatory credibility and clinical evidence. Consumer nicotine brings brand recognition and retail access. **The pharma-nicotine partnerships are a strategic response to a market that is converging: the distinction between pharmaceutical NRT and consumer nicotine is dissolving, and the companies that can navigate both worlds will dominate the converged market.**
